Einer Elhauge

Article Abstract:

Einer Elhauge, Professor of Law at Harvard Law School and the faculty director of new center, born to Argentinean parents, was an undergraduate in biochemical sciences and spent one year in medical school before taking a leave of absence to go to law school. Elhauge believes that leading law schools does not have much of a presence in health law and feels that biotechnology is one of the main cause of current health law issues.

Forecasts, trends, outlooks, Executive changes & profiles, Massachusetts, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Health Regulation, Usage, Officials and employees, Forecasts and trends, Beliefs, opinions and attitudes, Market trend/market analysis, Harvard Law School, Biotechnology, Medical law, Elhauge, Einer

---

Genentech discloses safety concerns over Avastin

Article Abstract:

Genentech and the US Food and Drug Administration (FDA) sent a notice to physicians regarding the Genentech's antibody drug, Avastin. The notice warns other companies that similar drugs targeting the endothelium may raise safety concerns when used in combination therapy.

Legal issues & crime, Company legal issue, Investigations, Biological products industry, Genentech Inc., Inspection, DNA, Avastin (Medication)

---

Cancer Pathways' target not validated by clinical results

Article Abstract:

Share prices of Cell Pathways dropped after reports that the Phase III clinical trial conducted on Exisulind did not achieve the expected results when compared to a placebo response.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Product information, Drugs, Brief Article, Cell Pathways Inc.

Similar abstracts:

• Abstracts: Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Serum proteomics profiling- a young technology begins to mature
• Abstracts: Oshkosh demonstrates new robotic truck. Officers: slat armor does not contribute to Stryker rollovers
• Abstracts: Shaping hedges. Charity changes. Global times
• Abstracts: 'Green' PR rises to meet challenges posed by new activist Congress. Little green 'buzz' reflects environmental progress
• Abstracts: Dual selection enhances the signaling specificity of a variant of the quorum-sensing transcriptional activator LuxR

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.